how to keep weight off after stopping glp 1 medication Maintain Loss GLP-1 – KETO-MOJO What Happens When You Stop

doi: 10.1007/s12192-011-0293-3 25 BenharM

Medications Certain medications can alter the way your taste buds function, resulting in a metallic or metallic-like taste

While GLP-1 receptor agonists like tirzepatide and semaglutide have revolutionized obesity treatment, emerging evidence suggests that strategic compounding with complementary agents may enhance therapeutic outcomes

Choose Mini for hydration + nausea relief, Plus for deeper nutrient replenishment, and Max for the strongest antioxidant recovery support

CagriSema vs Comparators Feature Receptor targets CagriSema Amylin/calcitonin + GLP-1 Tirzepatide (Zepbound) GIP + GLP-1 Semaglutide alone (Wegovy) GLP-1 Cagrilintide alone Amylin/calcitonin (DACRA) Feature Dosing frequency CagriSema Once weekly Tirzepatide (Zepbound) Once weekly Semaglutide alone (Wegovy) Once weekly Cagrilintide alone Once weekly Feature Maintenance dose CagriSema 2.4 mg + 2.4 mg Tirzepatide (Zepbound) Up to 15 mg Semaglutide alone (Wegovy) 2.4 mg Cagrilintide alone 2.4 mg (in REDEFINE arms) Feature Headline weight loss CagriSema 20.4% at 68 wks (REDEFINE 1, treatment-policy) Tirzepatide (Zepbound) Up to 22.5% at 72 wks (SURMOUNT-1, 15 mg arm) Semaglutide alone (Wegovy) 14.9% at 68 wks (REDEFINE 1 reference arm) Cagrilintide alone 11.5% at 68 wks (REDEFINE 1 reference arm) Feature FDA status (June 2026) CagriSema NDA filed Dec 2025

This product is much more effective than the B12